XML 47 R37.htm IDEA: XBRL DOCUMENT v3.25.4
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL CONSOLIDATED STATEMENT OF OPERATIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Revenue $ 345,968   $ 917,077   $ 541,293 $ 1,586,508
Less: shared revenue 209,621   782,495   308,018 974,384
Net revenue 136,347   134,582   233,275 612,124
Total operating expenses 273,320   170,802   478,462 375,702
Income (loss) from operations (136,973)   (36,220)   (245,187) 236,422
Income (loss) before provision for income taxes (144,760)   (45,195)   21,439 217,352
Provision for income taxes        
Net income (loss) $ (144,760) $ 166,199 $ (45,195) $ 262,547 $ 21,439 $ 217,352
Basic income per common share $ (0.00)   $ (0.00)   $ 0.00 $ 0.00
Diluted income per common share $ (0.00)   $ (0.00)   $ 0.00 $ 0.00
Net income (loss) $ (144,760) 166,199 $ (45,195) 262,547 $ 21,439 $ 217,352
Changes in operating assets and liabilities:            
Accounts receivable         (62,317)
Accounts payable         23,059 (17,032)
Accrued interest         15,123 18,819
Accrued executive compensation         (58,333)
Net cash (used in) provided by operating activities         (226,600) 98,489
Net cash provided (used) by investing activities        
Net cash provided (used) by financing activities         199,900 (150,340)
NET (DECREASE) IN CASH AND CASH EQUIVALENTS         (26,700) (51,851)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD   $ 68,108   115,747 68,108 115,747
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 41,408   63,896   $ 41,408 63,896
Previously Reported [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Revenue       669,431   1,586,508
Less: shared revenue       191,889   736,384
Net revenue       477,542   850,124
Total operating expenses       210,898   387,698
Income (loss) from operations       266,644   462,426
Interest expense       (10,095)   (19,070)
Income (loss) before provision for income taxes       256,549   443,356
Provision for income taxes        
Net income (loss)       $ 256,549   $ 443,356
Basic income per common share       $ 0.00   $ 0.00
Diluted income per common share       $ 0.00   $ 0.00
Net income (loss)       $ 256,549   $ 443,356
Adjustments to reconcile net income to net cash used in operating activities            
Depreciation       5,998   11,996
Changes in operating assets and liabilities:            
Accounts receivable       28,082   (62,317)
Accounts payable       (40,437)   (17,032)
Accrued interest       10,095   18,819
Accrued executive compensation       (43,173)   (58,333)
Net cash (used in) provided by operating activities       217,114   335,489
Net cash provided (used) by investing activities           (238,000)
Net cash provided (used) by financing activities       (40,000)   (150,340)
NET (DECREASE) IN CASH AND CASH EQUIVALENTS       177,114   (51,851)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD     292,861 115,747   115,747
CASH AND CASH EQUIVALENTS, END OF PERIOD     63,896 292,861   63,896
Revision of Prior Period, Reclassification, Adjustment [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Revenue        
Less: shared revenue         238,000
Net revenue         (238,000)
Total operating expenses       (5,998)   (11,996)
Income (loss) from operations       5,998   (226,004)
Interest expense        
Income (loss) before provision for income taxes       5,998   (226,004)
Provision for income taxes        
Net income (loss)       $ 5,998   $ (226,004)
Basic income per common share       $ 0.00   $ (0.00)
Diluted income per common share       $ 0.00   $ (0.00)
Net income (loss)       $ 5,998   $ (226,004)
Adjustments to reconcile net income to net cash used in operating activities            
Depreciation       (5,998)   (11,996)
Changes in operating assets and liabilities:            
Accounts receivable        
Accounts payable        
Accrued interest        
Accrued executive compensation        
Net cash (used in) provided by operating activities         (238,000)
Net cash provided (used) by investing activities           238,000
Net cash provided (used) by financing activities        
NET (DECREASE) IN CASH AND CASH EQUIVALENTS        
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD      
CASH AND CASH EQUIVALENTS, END OF PERIOD      
Restatement [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Revenue       669,431   1,586,508
Less: shared revenue       191,889   974,384
Net revenue       477,542   612,124
Total operating expenses       204,900   375,702
Income (loss) from operations       272,642   236,422
Interest expense       (10,095)   (19,070)
Income (loss) before provision for income taxes       262,547   217,352
Provision for income taxes        
Net income (loss)       $ 262,547   $ 217,352
Basic income per common share       $ 0.00   $ 0.00
Diluted income per common share       $ 0.00   $ 0.00
Net income (loss)       $ 262,547   $ 217,352
Adjustments to reconcile net income to net cash used in operating activities            
Depreciation        
Changes in operating assets and liabilities:            
Accounts receivable       28,082   (62,317)
Accounts payable       (40,437)   (17,032)
Accrued interest       10,095   18,819
Accrued executive compensation       (43,173)   (58,333)
Net cash (used in) provided by operating activities       217,114   98,489
Net cash provided (used) by investing activities          
Net cash provided (used) by financing activities       (40,000)   (150,340)
NET (DECREASE) IN CASH AND CASH EQUIVALENTS       177,114   (51,851)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD     292,861 115,747   115,747
CASH AND CASH EQUIVALENTS, END OF PERIOD     $ 63,896 $ 292,861   $ 63,896